The TGF-β1 target WISP1 is highly expressed in liver cirrhosis and cirrhotic HCC microenvironment and involved in pro- and anti-tumorigenic effects
WNT1-inducible signalling pathway protein 1 (WISP1) promotes progression of several tumor entities often correlating with worse prognosis. Here its expression regulation and role in the progression of chronic liver diseases (CLD) was investigated. WISP1 expression was analyzed in human HCC datasets,...
Saved in:
Published in | Biochemical and biophysical research communications Vol. 732; p. 150409 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier Inc
05.11.2024
|
Subjects | |
Online Access | Get full text |
ISSN | 0006-291X 1090-2104 1090-2104 |
DOI | 10.1016/j.bbrc.2024.150409 |
Cover
Loading…
Abstract | WNT1-inducible signalling pathway protein 1 (WISP1) promotes progression of several tumor entities often correlating with worse prognosis. Here its expression regulation and role in the progression of chronic liver diseases (CLD) was investigated.
WISP1 expression was analyzed in human HCC datasets, in biopsies and serum samples and an HCC patient tissue microarray (TMA) including correlation to clinicopathological parameters. Spatial distribution of WISP1 expression was determined using RNAscope analysis. Regulation of WISP1 expression was investigated in cytokine-stimulated primary mouse hepatocytes (PMH) by array analysis and qRT-PCR. Outcome of WISP1 stimulation was analyzed by IncuCyte S3-live cell imaging, qRT-PCR, and immunoblotting in murine AML12 cells.
In a TMA, high WISP1 expression was positively correlated with early HCC stages and male sex. Highest WISP1 expression levels were detected in patients with cirrhosis as compared to healthy individuals, patients with early fibrosis, and non-cirrhotic HCC in liver biopsies, expression datasets and serum samples. WISP1 transcripts were predominantly detected in hepatocytes of cirrhotic rather than tumorous liver tissue. High WISP1 expression was associated with better survival. In PMH, AML12 and HepaRG, WISP1 was identified as a specific TGF-β1 target gene. Accordingly, expression levels of both cytokines positively correlated in human HCC patient samples. WISP1-stimulation induced the expression of Bcl-xL, PCNA and p21 in AML12 cells.
WISP1 expression is induced by TGF-β1 in hepatocytes and is associated with cirrhotic liver disease. We propose a crucial role of WISP1 in balancing pro- and anti-tumorigenic effects during premalignant stages of CLD.
•WISP1 expression in liver tissue and the serum of cirrhosis patients is higher than in healthy individuals or HCC patients.•TGF-β1 induces WISP1 expression in hepatocytes.•Expression levels of TGF-β1 and WISP1 correlate in HCC patients.•High WISP1 expression in HCC liver tissue is associated with increased survival.•WISP1 balances proliferation, apoptosis and cell cycle control. |
---|---|
AbstractList | WNT1-inducible signalling pathway protein 1 (WISP1) promotes progression of several tumor entities often correlating with worse prognosis. Here its expression regulation and role in the progression of chronic liver diseases (CLD) was investigated. WISP1 expression was analyzed in human HCC datasets, in biopsies and serum samples and an HCC patient tissue microarray (TMA) including correlation to clinicopathological parameters. Spatial distribution of WISP1 expression was determined using RNAscope analysis. Regulation of WISP1 expression was investigated in cytokine-stimulated primary mouse hepatocytes (PMH) by array analysis and qRT-PCR. Outcome of WISP1 stimulation was analyzed by IncuCyte S3-live cell imaging, qRT-PCR, and immunoblotting in murine AML12 cells. In a TMA, high WISP1 expression was positively correlated with early HCC stages and male sex. Highest WISP1 expression levels were detected in patients with cirrhosis as compared to healthy individuals, patients with early fibrosis, and non-cirrhotic HCC in liver biopsies, expression datasets and serum samples. WISP1 transcripts were predominantly detected in hepatocytes of cirrhotic rather than tumorous liver tissue. High WISP1 expression was associated with better survival. In PMH, AML12 and HepaRG, WISP1 was identified as a specific TGF-β1 target gene. Accordingly, expression levels of both cytokines positively correlated in human HCC patient samples. WISP1-stimulation induced the expression of Bcl-xL, PCNA and p21 in AML12 cells. WISP1 expression is induced by TGF-β1 in hepatocytes and is associated with cirrhotic liver disease. We propose a crucial role of WISP1 in balancing pro- and anti-tumorigenic effects during premalignant stages of CLD. WNT1-inducible signalling pathway protein 1 (WISP1) promotes progression of several tumor entities often correlating with worse prognosis. Here its expression regulation and role in the progression of chronic liver diseases (CLD) was investigated.INTRODUCTIONWNT1-inducible signalling pathway protein 1 (WISP1) promotes progression of several tumor entities often correlating with worse prognosis. Here its expression regulation and role in the progression of chronic liver diseases (CLD) was investigated.WISP1 expression was analyzed in human HCC datasets, in biopsies and serum samples and an HCC patient tissue microarray (TMA) including correlation to clinicopathological parameters. Spatial distribution of WISP1 expression was determined using RNAscope analysis. Regulation of WISP1 expression was investigated in cytokine-stimulated primary mouse hepatocytes (PMH) by array analysis and qRT-PCR. Outcome of WISP1 stimulation was analyzed by IncuCyte S3-live cell imaging, qRT-PCR, and immunoblotting in murine AML12 cells.METHODSWISP1 expression was analyzed in human HCC datasets, in biopsies and serum samples and an HCC patient tissue microarray (TMA) including correlation to clinicopathological parameters. Spatial distribution of WISP1 expression was determined using RNAscope analysis. Regulation of WISP1 expression was investigated in cytokine-stimulated primary mouse hepatocytes (PMH) by array analysis and qRT-PCR. Outcome of WISP1 stimulation was analyzed by IncuCyte S3-live cell imaging, qRT-PCR, and immunoblotting in murine AML12 cells.In a TMA, high WISP1 expression was positively correlated with early HCC stages and male sex. Highest WISP1 expression levels were detected in patients with cirrhosis as compared to healthy individuals, patients with early fibrosis, and non-cirrhotic HCC in liver biopsies, expression datasets and serum samples. WISP1 transcripts were predominantly detected in hepatocytes of cirrhotic rather than tumorous liver tissue. High WISP1 expression was associated with better survival. In PMH, AML12 and HepaRG, WISP1 was identified as a specific TGF-β1 target gene. Accordingly, expression levels of both cytokines positively correlated in human HCC patient samples. WISP1-stimulation induced the expression of Bcl-xL, PCNA and p21 in AML12 cells.RESULTSIn a TMA, high WISP1 expression was positively correlated with early HCC stages and male sex. Highest WISP1 expression levels were detected in patients with cirrhosis as compared to healthy individuals, patients with early fibrosis, and non-cirrhotic HCC in liver biopsies, expression datasets and serum samples. WISP1 transcripts were predominantly detected in hepatocytes of cirrhotic rather than tumorous liver tissue. High WISP1 expression was associated with better survival. In PMH, AML12 and HepaRG, WISP1 was identified as a specific TGF-β1 target gene. Accordingly, expression levels of both cytokines positively correlated in human HCC patient samples. WISP1-stimulation induced the expression of Bcl-xL, PCNA and p21 in AML12 cells.WISP1 expression is induced by TGF-β1 in hepatocytes and is associated with cirrhotic liver disease. We propose a crucial role of WISP1 in balancing pro- and anti-tumorigenic effects during premalignant stages of CLD.CONCLUSIONSWISP1 expression is induced by TGF-β1 in hepatocytes and is associated with cirrhotic liver disease. We propose a crucial role of WISP1 in balancing pro- and anti-tumorigenic effects during premalignant stages of CLD. WNT1-inducible signalling pathway protein 1 (WISP1) promotes progression of several tumor entities often correlating with worse prognosis. Here its expression regulation and role in the progression of chronic liver diseases (CLD) was investigated. WISP1 expression was analyzed in human HCC datasets, in biopsies and serum samples and an HCC patient tissue microarray (TMA) including correlation to clinicopathological parameters. Spatial distribution of WISP1 expression was determined using RNAscope analysis. Regulation of WISP1 expression was investigated in cytokine-stimulated primary mouse hepatocytes (PMH) by array analysis and qRT-PCR. Outcome of WISP1 stimulation was analyzed by IncuCyte S3-live cell imaging, qRT-PCR, and immunoblotting in murine AML12 cells. In a TMA, high WISP1 expression was positively correlated with early HCC stages and male sex. Highest WISP1 expression levels were detected in patients with cirrhosis as compared to healthy individuals, patients with early fibrosis, and non-cirrhotic HCC in liver biopsies, expression datasets and serum samples. WISP1 transcripts were predominantly detected in hepatocytes of cirrhotic rather than tumorous liver tissue. High WISP1 expression was associated with better survival. In PMH, AML12 and HepaRG, WISP1 was identified as a specific TGF-β1 target gene. Accordingly, expression levels of both cytokines positively correlated in human HCC patient samples. WISP1-stimulation induced the expression of Bcl-xL, PCNA and p21 in AML12 cells. WISP1 expression is induced by TGF-β1 in hepatocytes and is associated with cirrhotic liver disease. We propose a crucial role of WISP1 in balancing pro- and anti-tumorigenic effects during premalignant stages of CLD. WNT1-inducible signalling pathway protein 1 (WISP1) promotes progression of several tumor entities often correlating with worse prognosis. Here its expression regulation and role in the progression of chronic liver diseases (CLD) was investigated. WISP1 expression was analyzed in human HCC datasets, in biopsies and serum samples and an HCC patient tissue microarray (TMA) including correlation to clinicopathological parameters. Spatial distribution of WISP1 expression was determined using RNAscope analysis. Regulation of WISP1 expression was investigated in cytokine-stimulated primary mouse hepatocytes (PMH) by array analysis and qRT-PCR. Outcome of WISP1 stimulation was analyzed by IncuCyte S3-live cell imaging, qRT-PCR, and immunoblotting in murine AML12 cells. In a TMA, high WISP1 expression was positively correlated with early HCC stages and male sex. Highest WISP1 expression levels were detected in patients with cirrhosis as compared to healthy individuals, patients with early fibrosis, and non-cirrhotic HCC in liver biopsies, expression datasets and serum samples. WISP1 transcripts were predominantly detected in hepatocytes of cirrhotic rather than tumorous liver tissue. High WISP1 expression was associated with better survival. In PMH, AML12 and HepaRG, WISP1 was identified as a specific TGF-β1 target gene. Accordingly, expression levels of both cytokines positively correlated in human HCC patient samples. WISP1-stimulation induced the expression of Bcl-xL, PCNA and p21 in AML12 cells. WISP1 expression is induced by TGF-β1 in hepatocytes and is associated with cirrhotic liver disease. We propose a crucial role of WISP1 in balancing pro- and anti-tumorigenic effects during premalignant stages of CLD. •WISP1 expression in liver tissue and the serum of cirrhosis patients is higher than in healthy individuals or HCC patients.•TGF-β1 induces WISP1 expression in hepatocytes.•Expression levels of TGF-β1 and WISP1 correlate in HCC patients.•High WISP1 expression in HCC liver tissue is associated with increased survival.•WISP1 balances proliferation, apoptosis and cell cycle control. |
ArticleNumber | 150409 |
Author | Tóth, Marcell Ilkavets, Iryna Caccamo, Tiziana Ebert, Matthias P. Rahbari, Nuh Breuhahn, Kai Weiss, Thomas S. Godoy, Patricio Finkelmeier, Fabian Meindl-Beinker, Nadja M. Alex, Sophie Hammad, Seddik Piiper, Albrecht Matter, Matthias S. Tong, Chenhao Feng, Teng Gonzalez, Daniela Dropmann, Anne Liebe, Roman Hengstler, Jan G. Waidmann, Oliver Rasbach, Erik Birgin, Emrullah Quagliata, Luca Schorn, Katharina Dooley, Steven Roessler, Stephanie |
Author_xml | – sequence: 1 givenname: Anne surname: Dropmann fullname: Dropmann, Anne organization: Department of Medicine II, Section Molecular Hepatology, Medical Faculty Mannheim, Heidelberg University, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany – sequence: 2 givenname: Sophie surname: Alex fullname: Alex, Sophie organization: Department of Medicine II, Section Molecular Hepatology, Medical Faculty Mannheim, Heidelberg University, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany – sequence: 3 givenname: Katharina surname: Schorn fullname: Schorn, Katharina organization: Department of Medicine II, Section Molecular Hepatology, Medical Faculty Mannheim, Heidelberg University, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany – sequence: 4 givenname: Chenhao surname: Tong fullname: Tong, Chenhao organization: Department of Medicine II, Section Molecular Hepatology, Medical Faculty Mannheim, Heidelberg University, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany – sequence: 5 givenname: Tiziana surname: Caccamo fullname: Caccamo, Tiziana organization: Department of Medicine II, Section Molecular Hepatology, Medical Faculty Mannheim, Heidelberg University, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany – sequence: 6 givenname: Patricio surname: Godoy fullname: Godoy, Patricio organization: Department of Medicine II, Section Molecular Hepatology, Medical Faculty Mannheim, Heidelberg University, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany – sequence: 7 givenname: Iryna surname: Ilkavets fullname: Ilkavets, Iryna organization: Department of Medicine II, Section Molecular Hepatology, Medical Faculty Mannheim, Heidelberg University, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany – sequence: 8 givenname: Roman orcidid: 0000-0002-3199-5595 surname: Liebe fullname: Liebe, Roman organization: Department of Medicine II, Section Molecular Hepatology, Medical Faculty Mannheim, Heidelberg University, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany – sequence: 9 givenname: Daniela surname: Gonzalez fullname: Gonzalez, Daniela organization: IfADo-Leibniz Research Centre for Working Environment and Human Factors, Technical University Dortmund, Ardeystr. 67, 44139, Dortmund, Germany – sequence: 10 givenname: Jan G. surname: Hengstler fullname: Hengstler, Jan G. organization: IfADo-Leibniz Research Centre for Working Environment and Human Factors, Technical University Dortmund, Ardeystr. 67, 44139, Dortmund, Germany – sequence: 11 givenname: Albrecht surname: Piiper fullname: Piiper, Albrecht organization: Department of Internal Medicine 1, University Hospital Frankfurt, Goethe University, Theodor-Stern-Kai 7, 60596, Frankfurt am Main, Germany – sequence: 12 givenname: Luca orcidid: 0000-0001-8249-9914 surname: Quagliata fullname: Quagliata, Luca organization: Institute of Pathology, University Hospital Basel, Schönbeinstrasse 40, 4031, Basel, Switzerland – sequence: 13 givenname: Matthias S. surname: Matter fullname: Matter, Matthias S. organization: Institute of Pathology, University Hospital Basel, Schönbeinstrasse 40, 4031, Basel, Switzerland – sequence: 14 givenname: Oliver surname: Waidmann fullname: Waidmann, Oliver organization: Department of Internal Medicine 1, University Hospital Frankfurt, Goethe University, Theodor-Stern-Kai 7, 60596, Frankfurt am Main, Germany – sequence: 15 givenname: Fabian orcidid: 0000-0001-8559-9910 surname: Finkelmeier fullname: Finkelmeier, Fabian organization: Department of Internal Medicine 1, University Hospital Frankfurt, Goethe University, Theodor-Stern-Kai 7, 60596, Frankfurt am Main, Germany – sequence: 16 givenname: Teng surname: Feng fullname: Feng, Teng organization: Department of Medicine II, Section Molecular Hepatology, Medical Faculty Mannheim, Heidelberg University, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany – sequence: 17 givenname: Thomas S. orcidid: 0000-0003-0336-0581 surname: Weiss fullname: Weiss, Thomas S. organization: Children's University Hospital (KUNO), Center for Liver Cell Research, University Hospital Regensburg, Josef-Engert-Straße 9, 93053, Regensburg, Germany – sequence: 18 givenname: Nuh surname: Rahbari fullname: Rahbari, Nuh organization: Department of Surgery and European Center of Angioscience (ECAS), Medical Faculty Mannheim, Heidelberg University, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany – sequence: 19 givenname: Emrullah surname: Birgin fullname: Birgin, Emrullah organization: Department of Surgery and European Center of Angioscience (ECAS), Medical Faculty Mannheim, Heidelberg University, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany – sequence: 20 givenname: Erik orcidid: 0000-0002-0807-3058 surname: Rasbach fullname: Rasbach, Erik organization: Department of General and Visceral Surgery, University Hospital Ulm, Albert-Einstein-Allee 23, 89081, Ulm, Germany – sequence: 21 givenname: Stephanie orcidid: 0000-0002-5333-5942 surname: Roessler fullname: Roessler, Stephanie organization: Institute of Pathology, University Hospital Heidelberg, Medical Faculty, Heidelberg University, Im Neuenheimer Feld 224, 69120, Heidelberg, Germany – sequence: 22 givenname: Kai surname: Breuhahn fullname: Breuhahn, Kai organization: Institute of Pathology, University Hospital Heidelberg, Medical Faculty, Heidelberg University, Im Neuenheimer Feld 224, 69120, Heidelberg, Germany – sequence: 23 givenname: Marcell surname: Tóth fullname: Tóth, Marcell organization: Institute of Pathology, University Hospital Heidelberg, Medical Faculty, Heidelberg University, Im Neuenheimer Feld 224, 69120, Heidelberg, Germany – sequence: 24 givenname: Matthias P. surname: Ebert fullname: Ebert, Matthias P. organization: Department of Medicine II, Medical Faculty Mannheim, Heidelberg University, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany – sequence: 25 givenname: Steven surname: Dooley fullname: Dooley, Steven organization: Department of Medicine II, Section Molecular Hepatology, Medical Faculty Mannheim, Heidelberg University, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany – sequence: 26 givenname: Seddik surname: Hammad fullname: Hammad, Seddik organization: Department of Medicine II, Section Molecular Hepatology, Medical Faculty Mannheim, Heidelberg University, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany – sequence: 27 givenname: Nadja M. orcidid: 0000-0003-0211-352X surname: Meindl-Beinker fullname: Meindl-Beinker, Nadja M. email: Nadja.Meindl-Beinker@umm.de organization: Department of Medicine II, Medical Faculty Mannheim, Heidelberg University, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/39033550$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkc2O0zAUhS00iOkMvAAL5CWblOu_NJbYoIr5kUYCiSLYWYlz07pK7GK7EfMePAkPwjORTjsbFsPKsvV9R9Y5F-TMB4-EvGYwZ8DKd9t500Q758DlnCmQoJ-RGQMNBWcgz8gMAMqCa_b9nFyktAVgTJb6BTkXGoRQCmbk12qDdHV9Vfz5zWiu4xoz_Xb75TOjLtGNW2_6e4o_dxFTwpY6T3s3YqTWxbgJaWJq355u2Vl6s1zSwdkY0I8uBj-gzw-I82Pox2PELobi4bH22RV5P4To1ugnHbsObU4vyfOu7hO-Op2X5OvVx9Xyprj7dH27_HBXWClELtqS6UXZatRgBas5soZzhd1CMsErayV2VYW6bEoA1LwGVaEEbHTbtFopKS7J22Pu9KMfe0zZDC5Z7PvaY9gnI5gS5UJxCf9HoRKclUryCX1zQvfNgK3ZRTfU8d48lj4B1RGYekopYmesy3V2wedYu94wMId9zdYc9jWHfc1x30nl_6iP6U9K748STl2ODqNJ1qG32Lo41W3a4J7S_wJ8xL7r |
CitedBy_id | crossref_primary_10_1002_adhm_202403227 |
Cites_doi | 10.1096/fj.202000953R 10.1016/j.cmet.2022.07.009 10.1620/tjem.252.297 10.3390/genes11060593 10.3322/caac.21654 10.3390/cancers14112798 10.1016/j.biocel.2015.03.007 10.1242/jcs.00653 10.1002/hep.30105 10.1002/jcp.29187 10.1007/s00418-006-0160-y 10.1053/j.gastro.2008.04.038 10.1007/s00204-016-1761-4 10.1002/1878-0261.12153 10.1038/srep20547 10.1053/j.gastro.2013.01.002 10.3390/cells10051048 10.2174/156720212799297137 10.1016/j.cgh.2007.02.039 10.1007/s10753-015-0218-x 10.1158/0008-5472.CAN-10-2607 10.2119/molmed.2008.00110 10.1038/ncb3378 10.1016/j.biocel.2014.06.011 10.3892/or.2015.3709 10.1152/ajpgi.00447.2014 10.1016/j.celrep.2019.03.031 10.1002/jcp.26449 10.1038/nrd3599 10.1172/JCI24282 10.7754/Clin.Lab.2013.121035 |
ContentType | Journal Article |
Copyright | 2024 The Authors Copyright © 2024 The Authors. Published by Elsevier Inc. All rights reserved. |
Copyright_xml | – notice: 2024 The Authors – notice: Copyright © 2024 The Authors. Published by Elsevier Inc. All rights reserved. |
DBID | 6I. AAFTH AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 7S9 L.6 |
DOI | 10.1016/j.bbrc.2024.150409 |
DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic AGRICOLA AGRICOLA - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic AGRICOLA AGRICOLA - Academic |
DatabaseTitleList | AGRICOLA MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Anatomy & Physiology Chemistry Biology |
EISSN | 1090-2104 |
ExternalDocumentID | 39033550 10_1016_j_bbrc_2024_150409 S0006291X24009458 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- --K --M -~X .~1 0R~ 1B1 1RT 1~. 1~5 23N 4.4 457 4G. 53G 5GY 5VS 6I. 6J9 7-5 71M 8P~ 9JM AABNK AACTN AAEDT AAEDW AAFTH AAHBH AAIKJ AAKOC AALRI AAOAW AAQFI AAXKI AAXUO ABFNM ABFRF ABGSF ABJNI ABMAC ABUDA ACDAQ ACGFO ACGFS ACNCT ACRLP ADBBV ADEZE ADUVX AEBSH AEFWE AEHWI AEKER AENEX AFFNX AFKWA AFTJW AFXIZ AGHFR AGUBO AGYEJ AIEXJ AIKHN AITUG AJOXV AKRWK ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ AXJTR BKOJK BLXMC CS3 D0L DM4 EBS EFBJH EO8 EO9 EP2 EP3 F5P FDB FIRID FNPLU FYGXN G-Q GBLVA IHE J1W K-O KOM L7B MO0 N9A O-L O9- OAUVE OZT P-8 P-9 P2P PC. Q38 RIG RNS ROL RPZ SCC SDF SDG SDP SES SEW SPCBC SSU SSZ T5K TWZ WH7 XPP XSW ZMT ~02 ~G- .55 .GJ .HR 1CY 3O- 9M8 AAQXK AATTM AAYJJ AAYWO AAYXX ABDPE ABEFU ABWVN ABXDB ACKIV ACRPL ACVFH ADCNI ADFGL ADIYS ADMUD ADNMO AEIPS AEUPX AFJKZ AFPUW AGCQF AGQPQ AGRDE AGRNS AHHHB AIGII AIIUN AKBMS AKYEP ANKPU APXCP ASPBG AVWKF AZFZN BNPGV CAG CITATION COF EJD FEDTE FGOYB G-2 HLW HVGLF HZ~ LG5 LX2 M41 MVM OHT R2- SBG SSH UQL WUQ X7M Y6R ZGI ZKB ~KM CGR CUY CVF ECM EFKBS EIF NPM 7X8 EFLBG 7S9 L.6 |
ID | FETCH-LOGICAL-c433t-d61976d9e90c31a2e1b225ef741328cc4ef88e96b600e92a058e40eb9dbd95543 |
IEDL.DBID | .~1 |
ISSN | 0006-291X 1090-2104 |
IngestDate | Thu Sep 04 22:05:30 EDT 2025 Fri Sep 05 06:14:46 EDT 2025 Mon Jul 21 05:59:56 EDT 2025 Thu Apr 24 23:12:30 EDT 2025 Tue Jul 01 04:30:04 EDT 2025 Sat Sep 07 15:50:32 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | Cirrhosis TGF-β1 HCC Chronic liver disease Proliferation WISP1 |
Language | English |
License | This is an open access article under the CC BY-NC license. Copyright © 2024 The Authors. Published by Elsevier Inc. All rights reserved. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c433t-d61976d9e90c31a2e1b225ef741328cc4ef88e96b600e92a058e40eb9dbd95543 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0001-8559-9910 0000-0002-0807-3058 0000-0003-0336-0581 0000-0002-5333-5942 0000-0002-3199-5595 0000-0003-0211-352X 0000-0001-8249-9914 |
OpenAccessLink | https://www.sciencedirect.com/science/article/pii/S0006291X24009458 |
PMID | 39033550 |
PQID | 3083216542 |
PQPubID | 23479 |
ParticipantIDs | proquest_miscellaneous_3153675240 proquest_miscellaneous_3083216542 pubmed_primary_39033550 crossref_citationtrail_10_1016_j_bbrc_2024_150409 crossref_primary_10_1016_j_bbrc_2024_150409 elsevier_sciencedirect_doi_10_1016_j_bbrc_2024_150409 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2024-11-05 |
PublicationDateYYYYMMDD | 2024-11-05 |
PublicationDate_xml | – month: 11 year: 2024 text: 2024-11-05 day: 05 |
PublicationDecade | 2020 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Biochemical and biophysical research communications |
PublicationTitleAlternate | Biochem Biophys Res Commun |
PublicationYear | 2024 |
Publisher | Elsevier Inc |
Publisher_xml | – name: Elsevier Inc |
References | Jun, Lau (bib7) 2011; 10 Pivovarova-Ramich, Loske, Hornemann, Markova, Seebeck, Rosenthal, Klauschen, Castro, Buschow, Grune, Lange, Rudovich, Ouwens (bib10) 2021; 10 Wang, Chong, Shang, Maiese (bib9) 2012; 9 Jung, Kang, Goh, Chae, Kim, Lee, Abd El-Aty, Jeong (bib24) 2018; 233 Wang, Gong, Zhang, Chen, Zhang, Lu, Yu, Han, Zhang, Chen, Zhang, Yuan, Huang, Zhang (bib33) 2017; 7 Karsdal, Manon-Jensen, Genovese, Kristensen, Nielsen, Sand, Hansen, Bay-Jensen, Bager, Krag, Blanchard, Krarup, Leeming, Schuppan (bib2) 2015; 308 Godoy, Widera, Schmidt-Heck, Campos, Meyer, Cadenas, Reif, Stober, Hammad, Putter, Gianmoena, Marchan, Ghallab, Edlund, Nussler, Thasler, Damm, Seehofer, Weiss, Dirsch, Dahmen, Gebhardt, Chaudhari, Meganathan, Sachinidis, Kelm, Hofmann, Zahedi, Guthke, Bluthgen, Dooley, Hengstler (bib15) 2016; 90 Siegel, Miller, Fuchs, Jemal (bib4) 2021; 71 Grinchuk, Yenamandra, Iyer, Singh, Lee, Lim, Chow, Kuznetsov (bib34) 2018; 12 Klee, Lehmann, Wagner, Baarsma, Konigshoff (bib18) 2016; 6 Korgun, Celik-Ozenci, Acar, Cayli, Desoye, Demir (bib28) 2006; 125 Chen, Xiang, Sun, Zhai, Gao, Fan, Wang (bib23) 2020; 252 Wang, Ding, Ding, Tesch, Zheng, Tian, Ricardo, Shen, Xue (bib20) 2020; 34 Gurbuz, Chiquet-Ehrismann (bib8) 2015; 62 Yan, Lei, Chen, Deng, Dong, Jin, Liu, Yuan, Qiu, Ge, Peng, Shao (bib12) 2018; 68 Mansilla, de la Vega, Calzetta, Siri, Gottifredi (bib29) 2020; 11 Mas, Maluf, Archer, Yanek, Kong, Kulik, Freise, Olthoff, Ghobrial, McIver, Fisher (bib35) 2009; 15 Jian, Wang, Dong, Hu, Hu, Yang, Zheng, Xiong (bib22) 2014; 60 Maga, Hubscher (bib27) 2003; 116 Roessler, Jia, Budhu, Forgues, Ye, Lee, Thorgeirsson, Sun, Tang, Qin, Wang (bib32) 2010; 70 Dooley, Hamzavi, Ciuclan, Godoy, Ilkavets, Ehnert, Ueberham, Gebhardt, Kanzler, Geier, Breitkopf, Weng, Mertens (bib16) 2008; 135 Yang, Wang, Tu, Li, Zou, Li, Wang, Zhong (bib26) 2020; 235 Galanos, Vougas, Walter, Polyzos, Maya-Mendoza, Haagensen, Kokkalis, Roumelioti, Gagos, Tzetis, Canovas, Igea, Ahuja, Zellweger, Havaki, Kanavakis, Kletsas, Roninson, Garbis, Lopes, Nebreda, Thanos, Blow, Townsend, Sorensen, Bartek, Gorgoulis (bib31) 2016; 18 Bataller, Brenner (bib1) 2005; 115 Xi, LaCanna, Ma, N'Diaye, Gierke, Caplazi, Sagolla, Huang, Lucio, Arlantico, Jeet, Brightbill, Emson, Wong, Morshead, DePianto, Roose-Girma, Yu, Tam, Jia, Ramalingam, Marsters, Ashkenazi, Kim, Kelly, Wu, Wolters, Feldstein, Vander Heiden, Ding (bib11) 2022; 34 Yang, Du, Xu, Jiang (bib19) 2016; 39 Zhang, Li, Huang, Lin, Ye, Lin, Koeffler, Wang, Yin (bib14) 2015; 33 Zhu, Li, Yang, Li, Zhao (bib25) 2020; 12 Ioannou, Splan, Weiss, McDonald, Beretta, Lee (bib6) 2007; 5 Chakraborty, Sarkar (bib5) 2022; 14 Sheng, Mendler, Rieke, Snyder, Jentsch, Friedrich, Drossel, Loewer (bib30) 2019; 27 Wang, Feng, Ji (bib13) 2020; 24 Hernandez-Gea, Toffanin, Friedman, Llovet (bib3) 2013; 144 Zhang, Meng, Yang, Mu (bib21) 2020; 24 Berschneider, Ellwanger, Baarsma, Thiel, Shimbori, White, Kolb, Neth, Konigshoff (bib17) 2014; 53 Yang (10.1016/j.bbrc.2024.150409_bib26) 2020; 235 Karsdal (10.1016/j.bbrc.2024.150409_bib2) 2015; 308 Hernandez-Gea (10.1016/j.bbrc.2024.150409_bib3) 2013; 144 Chakraborty (10.1016/j.bbrc.2024.150409_bib5) 2022; 14 Gurbuz (10.1016/j.bbrc.2024.150409_bib8) 2015; 62 Galanos (10.1016/j.bbrc.2024.150409_bib31) 2016; 18 Klee (10.1016/j.bbrc.2024.150409_bib18) 2016; 6 Sheng (10.1016/j.bbrc.2024.150409_bib30) 2019; 27 Godoy (10.1016/j.bbrc.2024.150409_bib15) 2016; 90 Roessler (10.1016/j.bbrc.2024.150409_bib32) 2010; 70 Jung (10.1016/j.bbrc.2024.150409_bib24) 2018; 233 Grinchuk (10.1016/j.bbrc.2024.150409_bib34) 2018; 12 Korgun (10.1016/j.bbrc.2024.150409_bib28) 2006; 125 Berschneider (10.1016/j.bbrc.2024.150409_bib17) 2014; 53 Jun (10.1016/j.bbrc.2024.150409_bib7) 2011; 10 Dooley (10.1016/j.bbrc.2024.150409_bib16) 2008; 135 Bataller (10.1016/j.bbrc.2024.150409_bib1) 2005; 115 Zhang (10.1016/j.bbrc.2024.150409_bib14) 2015; 33 Xi (10.1016/j.bbrc.2024.150409_bib11) 2022; 34 Wang (10.1016/j.bbrc.2024.150409_bib13) 2020; 24 Yang (10.1016/j.bbrc.2024.150409_bib19) 2016; 39 Zhu (10.1016/j.bbrc.2024.150409_bib25) 2020; 12 Ioannou (10.1016/j.bbrc.2024.150409_bib6) 2007; 5 Wang (10.1016/j.bbrc.2024.150409_bib20) 2020; 34 Jian (10.1016/j.bbrc.2024.150409_bib22) 2014; 60 Zhang (10.1016/j.bbrc.2024.150409_bib21) 2020; 24 Wang (10.1016/j.bbrc.2024.150409_bib9) 2012; 9 Chen (10.1016/j.bbrc.2024.150409_bib23) 2020; 252 Yan (10.1016/j.bbrc.2024.150409_bib12) 2018; 68 Pivovarova-Ramich (10.1016/j.bbrc.2024.150409_bib10) 2021; 10 Siegel (10.1016/j.bbrc.2024.150409_bib4) 2021; 71 Wang (10.1016/j.bbrc.2024.150409_bib33) 2017; 7 Mansilla (10.1016/j.bbrc.2024.150409_bib29) 2020; 11 Mas (10.1016/j.bbrc.2024.150409_bib35) 2009; 15 Maga (10.1016/j.bbrc.2024.150409_bib27) 2003; 116 |
References_xml | – volume: 27 start-page: 48 year: 2019 end-page: 58 e47 ident: bib30 article-title: PCNA-mediated degradation of p21 coordinates the DNA damage response and cell cycle regulation in individual cells publication-title: Cell Rep. – volume: 125 start-page: 615 year: 2006 end-page: 624 ident: bib28 article-title: Location of cell cycle regulators cyclin B1, cyclin A, PCNA, Ki67 and cell cycle inhibitors p21, p27 and p57 in human first trimester placenta and deciduas publication-title: Histochem. Cell Biol. – volume: 252 start-page: 297 year: 2020 end-page: 307 ident: bib23 article-title: Diagnostic value of the hypomethylation of the WISP1 promoter in patients with hepatocellular carcinoma associated with hepatitis B virus publication-title: Tohoku J. Exp. Med. – volume: 34 start-page: 14507 year: 2020 end-page: 14520 ident: bib20 article-title: WNT1-inducible-signaling pathway protein 1 regulates the development of kidney fibrosis through the TGF-beta1 pathway publication-title: Faseb. J. – volume: 70 start-page: 10202 year: 2010 end-page: 10212 ident: bib32 article-title: A unique metastasis gene signature enables prediction of tumor relapse in early-stage hepatocellular carcinoma patients publication-title: Cancer Res. – volume: 14 year: 2022 ident: bib5 article-title: Emerging therapies for hepatocellular carcinoma (HCC) publication-title: Cancers – volume: 10 year: 2021 ident: bib10 article-title: Hepatic Wnt1 inducible signaling pathway protein 1 (WISP-1/CCN4) associates with markers of liver fibrosis in severe obesity publication-title: Cells – volume: 24 start-page: 10445 year: 2020 end-page: 10451 ident: bib13 article-title: High expression of WISP1 promotes metastasis and predicts poor prognosis in hepatocellular carcinoma publication-title: Eur. Rev. Med. Pharmacol. Sci. – volume: 33 start-page: 1481 year: 2015 end-page: 1492 ident: bib14 article-title: Expression of CCN family members correlates with the clinical features of hepatocellular carcinoma publication-title: Oncol. Rep. – volume: 18 start-page: 777 year: 2016 end-page: 789 ident: bib31 article-title: Chronic p53-independent p21 expression causes genomic instability by deregulating replication licensing publication-title: Nat. Cell Biol. – volume: 12 start-page: 89 year: 2018 end-page: 113 ident: bib34 article-title: Tumor-adjacent tissue co-expression profile analysis reveals pro-oncogenic ribosomal gene signature for prognosis of resectable hepatocellular carcinoma publication-title: Mol. Oncol. – volume: 308 start-page: G807 year: 2015 end-page: G830 ident: bib2 article-title: Novel insights into the function and dynamics of extracellular matrix in liver fibrosis publication-title: Am. J. Physiol. Gastrointest. Liver Physiol. – volume: 71 start-page: 7 year: 2021 end-page: 33 ident: bib4 article-title: Cancer statistics publication-title: Ca - Cancer J. Clin. – volume: 10 start-page: 945 year: 2011 end-page: 963 ident: bib7 article-title: Taking aim at the extracellular matrix: CCN proteins as emerging therapeutic targets publication-title: Nat. Rev. Drug Discov. – volume: 60 start-page: 29 year: 2014 end-page: 35 ident: bib22 article-title: Wnt-induced secreted protein 1/CCN4 in liver fibrosis both in vitro and in vivo publication-title: Clin. Lab. – volume: 9 start-page: 20 year: 2012 end-page: 31 ident: bib9 article-title: Wnt1 inducible signaling pathway protein 1 (WISP1) blocks neurodegeneration through phosphoinositide 3 kinase/Akt1 and apoptotic mitochondrial signaling involving Bad, Bax, Bim, and Bcl-xL publication-title: Curr. Neurovascular Res. – volume: 5 start-page: 938 year: 2007 end-page: 945 ident: bib6 article-title: Incidence and predictors of hepatocellular carcinoma in patients with cirrhosis publication-title: Clin. Gastroenterol. Hepatol. – volume: 135 start-page: 642 year: 2008 end-page: 659 ident: bib16 article-title: Hepatocyte-specific Smad7 expression attenuates TGF-beta-mediated fibrogenesis and protects against liver damage publication-title: Gastroenterology – volume: 233 start-page: 6077 year: 2018 end-page: 6087 ident: bib24 article-title: WISP1 promotes non-alcoholic fatty liver disease and skeletal muscle insulin resistance via TLR4/JNK signaling publication-title: J. Cell. Physiol. – volume: 235 start-page: 2009 year: 2020 end-page: 2022 ident: bib26 article-title: WNT1-inducible signaling protein-1 mediates TGF-beta1-induced renal fibrosis in tubular epithelial cells and unilateral ureteral obstruction mouse models via autophagy publication-title: J. Cell. Physiol. – volume: 7 year: 2017 ident: bib33 article-title: Characterization of gene expression profiles in HBV-related liver fibrosis patients and identification of ITGBL1 as a key regulator of fibrogenesis publication-title: Sci. Rep. – volume: 24 start-page: 8675 year: 2020 end-page: 8684 ident: bib21 article-title: TGF-beta1/WISP1/Integrin-alpha interaction mediates human chondrocytes dedifferentiation publication-title: Eur. Rev. Med. Pharmacol. Sci. – volume: 11 year: 2020 ident: bib29 article-title: CDK-independent and PCNA-dependent functions of p21 in DNA replication publication-title: Genes – volume: 144 start-page: 512 year: 2013 end-page: 527 ident: bib3 article-title: Role of the microenvironment in the pathogenesis and treatment of hepatocellular carcinoma publication-title: Gastroenterology – volume: 39 start-page: 16 year: 2016 end-page: 29 ident: bib19 article-title: Functional effects of WNT1-inducible signaling pathway protein-1 on bronchial smooth muscle cell migration and proliferation in OVA-induced airway remodeling publication-title: Inflammation – volume: 115 start-page: 209 year: 2005 end-page: 218 ident: bib1 article-title: Liver fibrosis publication-title: J. Clin. Invest. – volume: 34 start-page: 1377 year: 2022 end-page: 1393 e1378 ident: bib11 article-title: A WISP1 antibody inhibits MRTF signaling to prevent the progression of established liver fibrosis publication-title: Cell Metabol. – volume: 62 start-page: 142 year: 2015 end-page: 146 ident: bib8 article-title: CCN4/WISP1 (WNT1 inducible signaling pathway protein 1): a focus on its role in cancer publication-title: Int. J. Biochem. Cell Biol. – volume: 53 start-page: 432 year: 2014 end-page: 441 ident: bib17 article-title: miR-92a regulates TGF-beta1-induced WISP1 expression in pulmonary fibrosis publication-title: Int. J. Biochem. Cell Biol. – volume: 116 start-page: 3051 year: 2003 end-page: 3060 ident: bib27 article-title: Proliferating cell nuclear antigen (PCNA): a dancer with many partners publication-title: J. Cell Sci. – volume: 68 start-page: 2268 year: 2018 end-page: 2284 ident: bib12 article-title: Human leukocyte antigen F locus adjacent transcript 10 overexpression disturbs WISP1 protein and mRNA expression to promote hepatocellular carcinoma progression publication-title: Hepatology – volume: 15 start-page: 85 year: 2009 end-page: 94 ident: bib35 article-title: Genes involved in viral carcinogenesis and tumor initiation in hepatitis C virus-induced hepatocellular carcinoma publication-title: Mol. Med. – volume: 12 start-page: 7297 year: 2020 end-page: 7311 ident: bib25 article-title: WISP1 indicates poor prognosis and regulates cell proliferation and apoptosis in gastric cancer via targeting AKT/mTOR signaling pathway publication-title: Am J Transl Res – volume: 6 year: 2016 ident: bib18 article-title: WISP1 mediates IL-6-dependent proliferation in primary human lung fibroblasts publication-title: Sci. Rep. – volume: 90 start-page: 2513 year: 2016 end-page: 2529 ident: bib15 article-title: Gene network activity in cultivated primary hepatocytes is highly similar to diseased mammalian liver tissue publication-title: Arch. Toxicol. – volume: 34 start-page: 14507 year: 2020 ident: 10.1016/j.bbrc.2024.150409_bib20 article-title: WNT1-inducible-signaling pathway protein 1 regulates the development of kidney fibrosis through the TGF-beta1 pathway publication-title: Faseb. J. doi: 10.1096/fj.202000953R – volume: 34 start-page: 1377 year: 2022 ident: 10.1016/j.bbrc.2024.150409_bib11 article-title: A WISP1 antibody inhibits MRTF signaling to prevent the progression of established liver fibrosis publication-title: Cell Metabol. doi: 10.1016/j.cmet.2022.07.009 – volume: 252 start-page: 297 year: 2020 ident: 10.1016/j.bbrc.2024.150409_bib23 article-title: Diagnostic value of the hypomethylation of the WISP1 promoter in patients with hepatocellular carcinoma associated with hepatitis B virus publication-title: Tohoku J. Exp. Med. doi: 10.1620/tjem.252.297 – volume: 11 year: 2020 ident: 10.1016/j.bbrc.2024.150409_bib29 article-title: CDK-independent and PCNA-dependent functions of p21 in DNA replication publication-title: Genes doi: 10.3390/genes11060593 – volume: 71 start-page: 7 year: 2021 ident: 10.1016/j.bbrc.2024.150409_bib4 article-title: Cancer statistics publication-title: Ca - Cancer J. Clin. doi: 10.3322/caac.21654 – volume: 14 year: 2022 ident: 10.1016/j.bbrc.2024.150409_bib5 article-title: Emerging therapies for hepatocellular carcinoma (HCC) publication-title: Cancers doi: 10.3390/cancers14112798 – volume: 62 start-page: 142 year: 2015 ident: 10.1016/j.bbrc.2024.150409_bib8 article-title: CCN4/WISP1 (WNT1 inducible signaling pathway protein 1): a focus on its role in cancer publication-title: Int. J. Biochem. Cell Biol. doi: 10.1016/j.biocel.2015.03.007 – volume: 116 start-page: 3051 year: 2003 ident: 10.1016/j.bbrc.2024.150409_bib27 article-title: Proliferating cell nuclear antigen (PCNA): a dancer with many partners publication-title: J. Cell Sci. doi: 10.1242/jcs.00653 – volume: 68 start-page: 2268 year: 2018 ident: 10.1016/j.bbrc.2024.150409_bib12 article-title: Human leukocyte antigen F locus adjacent transcript 10 overexpression disturbs WISP1 protein and mRNA expression to promote hepatocellular carcinoma progression publication-title: Hepatology doi: 10.1002/hep.30105 – volume: 12 start-page: 7297 year: 2020 ident: 10.1016/j.bbrc.2024.150409_bib25 article-title: WISP1 indicates poor prognosis and regulates cell proliferation and apoptosis in gastric cancer via targeting AKT/mTOR signaling pathway publication-title: Am J Transl Res – volume: 235 start-page: 2009 year: 2020 ident: 10.1016/j.bbrc.2024.150409_bib26 article-title: WNT1-inducible signaling protein-1 mediates TGF-beta1-induced renal fibrosis in tubular epithelial cells and unilateral ureteral obstruction mouse models via autophagy publication-title: J. Cell. Physiol. doi: 10.1002/jcp.29187 – volume: 125 start-page: 615 year: 2006 ident: 10.1016/j.bbrc.2024.150409_bib28 article-title: Location of cell cycle regulators cyclin B1, cyclin A, PCNA, Ki67 and cell cycle inhibitors p21, p27 and p57 in human first trimester placenta and deciduas publication-title: Histochem. Cell Biol. doi: 10.1007/s00418-006-0160-y – volume: 135 start-page: 642 year: 2008 ident: 10.1016/j.bbrc.2024.150409_bib16 article-title: Hepatocyte-specific Smad7 expression attenuates TGF-beta-mediated fibrogenesis and protects against liver damage publication-title: Gastroenterology doi: 10.1053/j.gastro.2008.04.038 – volume: 90 start-page: 2513 year: 2016 ident: 10.1016/j.bbrc.2024.150409_bib15 article-title: Gene network activity in cultivated primary hepatocytes is highly similar to diseased mammalian liver tissue publication-title: Arch. Toxicol. doi: 10.1007/s00204-016-1761-4 – volume: 24 start-page: 8675 year: 2020 ident: 10.1016/j.bbrc.2024.150409_bib21 article-title: TGF-beta1/WISP1/Integrin-alpha interaction mediates human chondrocytes dedifferentiation publication-title: Eur. Rev. Med. Pharmacol. Sci. – volume: 7 year: 2017 ident: 10.1016/j.bbrc.2024.150409_bib33 article-title: Characterization of gene expression profiles in HBV-related liver fibrosis patients and identification of ITGBL1 as a key regulator of fibrogenesis publication-title: Sci. Rep. – volume: 12 start-page: 89 year: 2018 ident: 10.1016/j.bbrc.2024.150409_bib34 article-title: Tumor-adjacent tissue co-expression profile analysis reveals pro-oncogenic ribosomal gene signature for prognosis of resectable hepatocellular carcinoma publication-title: Mol. Oncol. doi: 10.1002/1878-0261.12153 – volume: 6 year: 2016 ident: 10.1016/j.bbrc.2024.150409_bib18 article-title: WISP1 mediates IL-6-dependent proliferation in primary human lung fibroblasts publication-title: Sci. Rep. doi: 10.1038/srep20547 – volume: 144 start-page: 512 year: 2013 ident: 10.1016/j.bbrc.2024.150409_bib3 article-title: Role of the microenvironment in the pathogenesis and treatment of hepatocellular carcinoma publication-title: Gastroenterology doi: 10.1053/j.gastro.2013.01.002 – volume: 10 year: 2021 ident: 10.1016/j.bbrc.2024.150409_bib10 article-title: Hepatic Wnt1 inducible signaling pathway protein 1 (WISP-1/CCN4) associates with markers of liver fibrosis in severe obesity publication-title: Cells doi: 10.3390/cells10051048 – volume: 9 start-page: 20 year: 2012 ident: 10.1016/j.bbrc.2024.150409_bib9 article-title: Wnt1 inducible signaling pathway protein 1 (WISP1) blocks neurodegeneration through phosphoinositide 3 kinase/Akt1 and apoptotic mitochondrial signaling involving Bad, Bax, Bim, and Bcl-xL publication-title: Curr. Neurovascular Res. doi: 10.2174/156720212799297137 – volume: 5 start-page: 938 year: 2007 ident: 10.1016/j.bbrc.2024.150409_bib6 article-title: Incidence and predictors of hepatocellular carcinoma in patients with cirrhosis publication-title: Clin. Gastroenterol. Hepatol. doi: 10.1016/j.cgh.2007.02.039 – volume: 39 start-page: 16 year: 2016 ident: 10.1016/j.bbrc.2024.150409_bib19 article-title: Functional effects of WNT1-inducible signaling pathway protein-1 on bronchial smooth muscle cell migration and proliferation in OVA-induced airway remodeling publication-title: Inflammation doi: 10.1007/s10753-015-0218-x – volume: 70 start-page: 10202 year: 2010 ident: 10.1016/j.bbrc.2024.150409_bib32 article-title: A unique metastasis gene signature enables prediction of tumor relapse in early-stage hepatocellular carcinoma patients publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-10-2607 – volume: 15 start-page: 85 year: 2009 ident: 10.1016/j.bbrc.2024.150409_bib35 article-title: Genes involved in viral carcinogenesis and tumor initiation in hepatitis C virus-induced hepatocellular carcinoma publication-title: Mol. Med. doi: 10.2119/molmed.2008.00110 – volume: 18 start-page: 777 year: 2016 ident: 10.1016/j.bbrc.2024.150409_bib31 article-title: Chronic p53-independent p21 expression causes genomic instability by deregulating replication licensing publication-title: Nat. Cell Biol. doi: 10.1038/ncb3378 – volume: 53 start-page: 432 year: 2014 ident: 10.1016/j.bbrc.2024.150409_bib17 article-title: miR-92a regulates TGF-beta1-induced WISP1 expression in pulmonary fibrosis publication-title: Int. J. Biochem. Cell Biol. doi: 10.1016/j.biocel.2014.06.011 – volume: 33 start-page: 1481 year: 2015 ident: 10.1016/j.bbrc.2024.150409_bib14 article-title: Expression of CCN family members correlates with the clinical features of hepatocellular carcinoma publication-title: Oncol. Rep. doi: 10.3892/or.2015.3709 – volume: 24 start-page: 10445 year: 2020 ident: 10.1016/j.bbrc.2024.150409_bib13 article-title: High expression of WISP1 promotes metastasis and predicts poor prognosis in hepatocellular carcinoma publication-title: Eur. Rev. Med. Pharmacol. Sci. – volume: 308 start-page: G807 year: 2015 ident: 10.1016/j.bbrc.2024.150409_bib2 article-title: Novel insights into the function and dynamics of extracellular matrix in liver fibrosis publication-title: Am. J. Physiol. Gastrointest. Liver Physiol. doi: 10.1152/ajpgi.00447.2014 – volume: 27 start-page: 48 year: 2019 ident: 10.1016/j.bbrc.2024.150409_bib30 article-title: PCNA-mediated degradation of p21 coordinates the DNA damage response and cell cycle regulation in individual cells publication-title: Cell Rep. doi: 10.1016/j.celrep.2019.03.031 – volume: 233 start-page: 6077 year: 2018 ident: 10.1016/j.bbrc.2024.150409_bib24 article-title: WISP1 promotes non-alcoholic fatty liver disease and skeletal muscle insulin resistance via TLR4/JNK signaling publication-title: J. Cell. Physiol. doi: 10.1002/jcp.26449 – volume: 10 start-page: 945 year: 2011 ident: 10.1016/j.bbrc.2024.150409_bib7 article-title: Taking aim at the extracellular matrix: CCN proteins as emerging therapeutic targets publication-title: Nat. Rev. Drug Discov. doi: 10.1038/nrd3599 – volume: 115 start-page: 209 year: 2005 ident: 10.1016/j.bbrc.2024.150409_bib1 article-title: Liver fibrosis publication-title: J. Clin. Invest. doi: 10.1172/JCI24282 – volume: 60 start-page: 29 year: 2014 ident: 10.1016/j.bbrc.2024.150409_bib22 article-title: Wnt-induced secreted protein 1/CCN4 in liver fibrosis both in vitro and in vivo publication-title: Clin. Lab. doi: 10.7754/Clin.Lab.2013.121035 |
SSID | ssj0011469 |
Score | 2.4780412 |
Snippet | WNT1-inducible signalling pathway protein 1 (WISP1) promotes progression of several tumor entities often correlating with worse prognosis. Here its expression... |
SourceID | proquest pubmed crossref elsevier |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 150409 |
SubjectTerms | Animals Apoptosis - genetics blood serum Carcinogenesis - genetics CCN Intercellular Signaling Proteins - genetics CCN Intercellular Signaling Proteins - metabolism Cell Cycle Checkpoints - genetics Cell Proliferation - genetics Chronic liver disease Cirrhosis cytokines data collection Female fibrosis Gene Expression Profiling Gene Expression Regulation, Neoplastic genes HCC hepatocytes Hepatocytes - metabolism Humans immunoblotting liver liver cirrhosis Liver Cirrhosis - genetics Liver Cirrhosis - pathology Liver Neoplasms - genetics Liver Neoplasms - pathology Male males Mice microarray technology neoplasms patients prognosis Proliferation Survival Analysis TGF-β1 Transforming Growth Factor beta1 - genetics Transforming Growth Factor beta1 - metabolism Tumor Microenvironment - genetics WISP1 |
Title | The TGF-β1 target WISP1 is highly expressed in liver cirrhosis and cirrhotic HCC microenvironment and involved in pro- and anti-tumorigenic effects |
URI | https://dx.doi.org/10.1016/j.bbrc.2024.150409 https://www.ncbi.nlm.nih.gov/pubmed/39033550 https://www.proquest.com/docview/3083216542 https://www.proquest.com/docview/3153675240 |
Volume | 732 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NbhMxELaqIgQXBC0_KVAZCXFBbr1rrxMfw4qQgqiQaEVulr07FYuSTZWfil54Cp6EB-GZmNn1RiBBDtzi1XjjZGZnvkm-mWHsORSAqKAsBMLRUujE94XH1FaYPkDQRgbpKVF8f2rG5_rtJJvssLyrhSFaZfT9rU9vvHW8chy_zePLqqIaX2lSm0yIBWl1RgW_Wvepf_7Rtw3Ng4puIwQ2gqRj4UzL8QphQW0MU32EuEgTKfHvwelf4LMJQqO77E5Ej3zYHvAe24F6j-0Pa8ycZ9f8BW_4nM0P5Xvs5qvu1a28m-q2z76jXfCzNyPx80fCWxo4_3Ty8UPCqyWn3sXTaw5fG3YslLyq-ZSIG7yoFovP8yXK-LqMKzwDH-c5nxGn77eCuUakqtHvXbW3wI8lmouoxUqs1jOaxgU1bo9skvvsfPT6LB-LOJlBFFqplSgx7eqb0oKVhUp8CklAvwAXCE9UOigKDReDAVgTEE6BTb3MBqAlBFuG0iKAUQ_Ybj2v4RHjHnCJb4Yx0mivyhAKBBXGeszk0LqyHks6lbgiti2n6RlT1_HTvjhSoyM1ulaNPfZys-eybdqxVTrrNO3-MD2HUWXrvmedWThUIv3R4muYr5dOSZr_RKPAtshgqMFkDY23xx62NrU5q7JSIQ6UB_95ssfsNq2aksnsCdtdLdbwFLHTKhw2D8chuzE8eTc-_QW9mhiy |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NbtNAEF6VIlQuCFoo4XeREBe0re1dO95jsQgptBUSqchttWtPhVGyqfKD6IWn4El4EJ6JGXsdgQQ5cPM6s_Y6M5n5Jv5mh7HnUAKigqoUCEcroWLbFxZTW5H1AZzKIhdZShRPz7LhuXo7TsdbrOhqYYhWGXx_69Mbbx3OHIZv8_CyrqnGN8oSHY-JBalVml9j11Uq-2TaB9_WPA-qug0YOBMkHipnWpKXc3PaxzBRBwiMFLES_x6d_oU-myg0uM1uBfjIj9oV3mFb4HfZ3pHH1Hl6xV_whtDZ_FO-y2686o52iq6t2x77jobBR28G4uePmLc8cP7x-MP7mNcLTpsXT644fG3osVDx2vMJMTd4Wc_nn2YLlLG-CiNcAx8WBZ8Sqe-3irlGpPbo-L60l8DHEs1JVGMtlqspteMCj9MDneQuOx-8HhVDEVoziFJJuRQV5l39rNKgo1LGNoHYoWOAC8QnMsnLUsFFnoPOHOIp0ImN0hxUBE5XrtKIYOQ9tu1nHu4zbgGHeDMMkpmysnKuRFSRaYupHJpX2mNxpxJThn3LqX3GxHQEtc-G1GhIjaZVY4-9XM-5bHft2Ciddpo2f9iewbCycd6zziwMKpHetFgPs9XCyIgaQFEvsA0yGGswW0Pr7bH91qbWa5U6kggEowf_ubKnbGc4Oj0xJ8dn7x6ym_RJUz-ZPmLby_kKHiOQWronzQ_lFxMQGkg |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+TGF-%CE%B21+target+WISP1+is+highly+expressed+in+liver+cirrhosis+and+cirrhotic+HCC+microenvironment%2C+involved+in+pro-+and+anti-tumorigenic+effects&rft.jtitle=Biochemical+and+biophysical+research+communications&rft.au=Dropmann%2C+Anne&rft.au=Alex%2C+Sophie&rft.au=Schorn%2C+Katharina&rft.au=Tong%2C+Chenhao&rft.date=2024-11-05&rft.issn=0006-291X&rft_id=info:doi/10.1016%2Fj.bbrc.2024.150409&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0006-291X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0006-291X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0006-291X&client=summon |